CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −10,000 | $80.06 | $801K | 837,991 |
| 2026-09-01 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −4,601 | $73.86 | $340K | 18,707 |
| 2026-06-25 | Goodrich Katherine Director | Grant or award · Stock Option (right to buy) | +3,837 | 3,837 | ||
| 2026-06-25 | Goodrich Katherine Director | Grant or award · Restricted Stock Units | +2,417 | 2,417 | ||
| 2026-06-25 | Goldberg Andrew D. Director | Grant or award · Stock Option (right to buy) | +3,837 | 3,837 | ||
| 2026-06-25 | Goldberg Andrew D. Director | Grant or award · Restricted Stock Units | +2,417 | 2,417 | ||
| 2026-06-25 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +3,837 | 3,837 | ||
| 2026-06-25 | Morrison Scott W Director | Grant or award · Restricted Stock Units | +2,417 | 2,417 | ||
| 2026-06-25 | CHAUDHURI BHASKAR Director | Grant or award · Stock Option (right to buy) | +3,837 | 3,837 | ||
| 2026-06-25 | CHAUDHURI BHASKAR Director | Grant or award · Restricted Stock Units | +2,417 | 2,417 | ||
| 2026-06-25 | LINK WILLIAM J PHD Director | Grant or award · Stock Option (right to buy) | +3,837 | 3,837 | ||
| 2026-06-25 | LINK WILLIAM J PHD Director | Grant or award · Restricted Stock Units | +2,417 | 2,417 | ||
| 2026-06-25 | LINK WILLIAM J PHD Director | Grant or award · Restricted Stock Units | +806 | 806 | ||
| 2026-06-25 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +3,837 | 3,837 | ||
| 2026-06-25 | YARNO WENDY L Director | Grant or award · Restricted Stock Units | +2,417 | 2,417 | ||
| 2026-06-25 | YARNO WENDY L Director | Grant or award · Restricted Stock Units | +1,209 | 1,209 | ||
| 2026-06-25 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +3,837 | 3,837 | ||
| 2026-06-25 | PYOTT DAVID E I Director | Grant or award · Restricted Stock Units | +2,417 | 2,417 | ||
| 2026-06-25 | PYOTT DAVID E I Director | Grant or award · Restricted Stock Units | +806 | 806 | ||
| 2026-06-17 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −4,582 | $61.24 | $281K | 853,409 |
Page 2 of 13 · 257 trades